The hallmark of CDH is a rupture of the diaphragm that allows organs found in the lower abdomen, such as the liver, spleen, and intestines, to push their way into the chest cavity. The invading organs crowd the limited space and can lead to abnormal lung and heart development or poor heart and lung function, which, depending on the severity of the condition, can cause disability or death.
In a paper published recently in the
"We now have a really good picture of this abnormality in mice, and we suspect it is very similar in humans," said Fuming Zhang, a research professor in the laboratory of
The discovery began with the observation that mice bred without the NDST1 gene, which produces the eponymous NDST1 enzyme, are more likely to develop CDH than ordinary mice. The enzyme NDST1 is one of four isoforms - a group of molecules that are chemically similar, but show subtle functional differences. In mice lacking the NDST1 gene, and therefore the NDST1 enzyme, nature substitutes with an NDST1 isoform (NDST2, NDST3, and NDST4), but the results - like substitutions in cooking - are noticeable.
In the absence of NDST1, blood vessels supplying the developing diaphragm muscles formed inconsistently, leading to weak points in the muscle tissues that make them prone to hernia. Researchers knew that the NDST1 enzyme is involved in the synthesis of heparan sulfate, so the group turned to the Linhardt's research team at Rensselaer - experts in heparan sulfate and glycosaminoglycan analysis - to pinpoint the biochemical basis for the abnormality.
"There are two molecules in the interaction that leads to proper blood vessel formation in the diaphragm - NDST1 biosynthesized heparan sulfate and the protein SLIT3," said Zhang. "In order for those interactions to be successful, and for blood vessels to form properly, everything must be accomplished within a specific time frame and having a specific structure. We were able to investigate the interactions between the two."
Zhang used surface plasmon resonance spectroscopy to measure aspects of the interaction such as the rate at which the two molecules bound together, the strength of their interaction, and the molecular structure of heparan sulfate required for a successful interaction. The results of his measurements explain the inconsistent blood vessel growth and weak muscle tissue observed in the mice.
"The binding strength, the binding rate, and the length of the heparan sulfate required for binding to the SLIT3 protein are inadequate for the job in this defect," said Zhang. "We were able to understand why, at a molecular level, this failure in development takes place."
Linhardt said the findings allow researchers to think about "routes for intervention at all levels." Gene therapy might supply the correct gene, drugs might deliver a substitute molecule, tissue engineering might enable the tissue to repair itself, or a surgeon might repair the damage after a hernia has occurred.
"We understand that the muscle is damaged because blood flow is damaged because the vascular system feeding the blood flow isn't forming properly," said Linhardt. "Because we now understand what is wrong, it allows us to think about the opportunity for therapy at all levels."
Keywords for this news article include: Biotechnology, Genetics, Gene Therapy, Bioengineering, Enzymes and Coenzymes,
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Most Popular Stories
- Reid: Bundy Backers Are 'Domestic Terrorists'
- Ex-BP Employee Settles Insider Trading Charges
- Twitter Offers App Install Ads
- Judge Tells Dad to Quit Emailing His Kids in All Caps
- 'Boats 'N Hoes' PAC Sunk by Complaint
- Natural Gas Shoots Up on Bullish Stockpile Report
- Naya Rivera and Lea Michele: The 'Glee' Fight That Never Was?
- Larry Flynt Won't Stop Sending Porn to Congress
- Legalize Marijuana But Not Hard Drugs, Say Americans
- Michaels Data Breach May Affect 2.6 Million Cards